Cardioprotection with the KATP opener cromakalim is not correlated with ischemic myocardial action potential duration

Journal of Cardiovascular Pharmacology

Volumn 26, Issue 1, 1995, Pages 145-152

  Grover, Gary J ^a   D’alonzo, Albert J ^a   Parham, Charles S ^a   Darbenzio, Raymond B ^a  

^a BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

Author keywords

Action potential duration; Cardioprotection; Cromakalim; Ischemia

Indexed keywords

CROMAKALIM; DOFETILIDE; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; ADENOSINE TRIPHOSPHATE; ANTI ARRHYTHMIA AGENTS; ANTIARRHYTHMIC AGENT; BENZOPYRAN DERIVATIVE; PHENETHYLAMINE DERIVATIVE; PYRROLE DERIVATIVE; SULFONAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRADYCARDIA; DOG; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE POTENTIAL; HEART PROTECTION; INTRACORONARY INFUSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; ACTION POTENTIAL; ANIMAL; BLOOD FLOW; DOSE RESPONSE; DRUG COMBINATION; PATHOPHYSIOLOGY; POTASSIUM CHANNEL; REPERFUSION INJURY;

ACTION POTENTIALS; ADENOSINE TRIPHOSPHATE; ANIMAL; ANTI-ARRHYTHMIA AGENTS; BENZOPYRANS; CROMAKALIM; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; INFUSIONS, INTRAVENOUS; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; PHENETHYLAMINES; POTASSIUM CHANNELS; PYRROLES; REGIONAL BLOOD FLOW; SULFONAMIDES;

EID: 0028989362     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/00005344-199507000-00023     Document Type: Article

References (27)

1. Galifianes M, Shattock MJ, Hearse DJ. Effects of potassium channel modulation during global ischaemia in isolated rat heart with and without cardioplegia. Cardiovasc Res 1992;26:1063-8.
2. + channel opener aprikalim (RP 52891) reduces experimental infarct size in dogs in the absence of hemodynamic changes. J Pharmacol Exp Ther 1991;259:961-7.
3. Cole WC, McPherson CD, Sontag D. ATP-regulated channels protect the myocardium against ischemia/reperfusion damage. Circ Res 1991;69:571-81.
4. Grover GJ, Dzwonczyk S, Sleph PG. Reduction of ischemic damage in isolated rat hearts by the postassium channel opener RP 52891. Eur J Pharmacol 1990;191:11-9.
5. Toombs CF, McGee DS, Johnston WE, Vinten-Johansen J. Protection from ischaemic-reprefusion injury with adenosine pretreatment is reversed by inhibition of ATP-sensitive potassium channels. Cardiovasc Res 1993;27:623-9.
6. Gross GJ. Auchampach JA. Blockade of ATP-sensitive potassium channel prevents myocardial preconditioning in dogs. Circ Res 1992;70:223-39.
7. Atwal KS, Grover GJ, Ahmed S, et al. Cardioselective anti-ischemic ATP-sensitive potassium channel openers. J Med Chem 1993;36:3971-4.
8. + current activated by pinacidil. Circ Res 1991;68:1127-37.
9. Fish FA, Prakash C, Roden DM. Suppression of repolarization-related arrhythmias in vitro and in vivo by low-dose potassium channel activators. Circulation 1990;82:1362-6.
10. Chi L, Uprichard ACG, Lucchesi BR. Profibrillatory actions of pinacidil in a conscious canine model of sudden coronary death. J Cardiovasc Pharmacol 1990;15:452-64.
11. Yao Z, GJ Gross. Effects of the Katp channel opener bi-makalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Circulation 1994;89:1769-75.
12. Zuanetti G, Corr PB. Antiarrhythmic efficacy of a new class III agent, UK-68,798, during chronic myocardial infarction: Evaluation using three-dimensional mapping. J Pharmacol Exp Ther 1991;256:325-34.
13. Knilans TK, Lathrop DA, Nanasi PP, Schwartz A, Varro A. Rate-dependent electrophysiological effects of UK-68,798, a new highly potent class III antiarrhythmic. Br J Pharmacol 1991;103:1568-72.
14. + current by dofetilide. Circ Res 1993;72:75-83.
15. Sargent CA, Smith MA, Dzwonczyk S, Sleph PG, Grover GJ. Effect of potassium channel blockade on the anti-isch-emic actions of mechanistically diverse agents. J Pharmacol Exp Ther 1991;259:97-103.
16. Warltier DC, Zyvoloski MG, Gross GJ, Hardman HF, Brooks HL. Determination of experimental myocardial infarct size. J Pharmacol Methods 1981;6:199-210.
17. Grover GJ, McCullough JR, Henry DE, Conder ML, Sleph PG. Anti-ischemic effects of the potassium channels activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide. J Pharmacol Exp Ther 1989;251:98-104.
18. D'Alonzo AJ. Darbenzio RB, Parham CS, Grover GJ. Effects of intracoronary cromakalim on postischaemic contractile function and action potential duration. Cardiovasc Res 1992;26:1046-53.
19. Ohta H, Jinno Y, Harada K, Ogawa N, Fukushima, Nishikore J. Cardioprotective effects of KRN2391 and nicorandil on ischemic dysfunction in perfused rat heart. Eur J Pharmacol 1991;204:171-7.
20. Sargent CA, Dzwonczyk S, Grover GJ. Effect of the potassium channel opener EMD 56431 on globally ischemic rat hearts. Pharmacology 1992;45:260-8.
21. + channel-dependent as well as independent components of pinacidil-induced vasodilation. J Pharmacol Exp Ther 1991;256:492-9.
22. + channels? Trends Pharmacol Sci 1993;14:332-7.
23. + channel in the mitochondrial inner membrane. Nature 1991;352:244-7.
24. MacKenzie I, Saville VL, Waterfall JF. Differential class III and glibenclamide effects on action potential duration in guinea-pig papillary muscle during normoxia/ischaemia. Br J Pharmacol 1993;110:531-8.
25. Fish FA, Prakash C, Roden DM. Suppression of repolariza-tion-related arrhythmias in vitro and in vivo by low-dose potassium channel activators. Circulation 1990;82:1362-9.
26. D'Alonzo AJ, Darbenzio RB, Hess TA, Sewter JC, Sleph PG, Grover GJ. Effect of potassium on the action of the KAtp modulators cromakalim, pinacidil, or glibenclamide on arrhythmias in isolated perfused rat heart subjected to regional ischemia. Cardiovasc Res 1994;28:881-7.
27. Grover GJ. Protective effects of ATP-sensitive potassium channel openers in experimental models of myocardial ischemia. J Cardiovasc Pharmacol 1994;24(suppl 4):S18-27.